Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
Nespresso, the worldwide reference for highest-quality portioned premium coffee, announced today the launch of the second phase of its television advertising campaign “The best café. Yours.” The U.S. and Canada campaign further increases brand awareness among coffee lovers amidst the recent growth of the single serve coffee market. Nespresso has enlisted Oscar-winning actress and coffee lover Penelope Cruz to star in the 30-second television spot as she epitomizes the sophistication, elegance and passion of the brand.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59154-nespresso-what-else-penelope-cruz
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
Fluke Corporation, the global leader in portable electronic test and measurement technology, announces the availability of the Fluke® 430 Series II Three Phase Power Analyzers, the first tools to use a patented algorithm to measure energy wasted by power quality issues and quantify its cost. By providing the ROI data needed to justify power quality improvements, the 430 Series II helps facilities reduce electrical power consumption and improve the performance and lifespan of electro-mechanical equipment.
To view Multimedia News Release, go to MNR http://www.multivu.com/mnr/54283-fluke-435-three-phase-power-quality-analyzer-test-generators-motors
Made to your greatest good results at Mixed Martial Arts is our MMA office in Clinton, Maryland. After you phase into our office, you’ll quickly realize that this is certainly no ordinary mixed martial arts academy, but is something genuinely exceptional.
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
Kubota Tractor Corporation has announced the availability of its second phase of all-new Kubota Hay Tools in dealerships nationwide. The recently expanded hay tools line brings to market new round balers and turntable bale wrappers; side-mounted and trailed disc mowers; trailed mower conditioners; and a complete range of rotary tedders and rakes.
The new machinery is designed specifically for the U.S. market to further expand Kubota's presence in the larger agricultural product market. "With our extended line of hay tools, we are building on the success of our well-received initial hay tools launch last year and responding to outstanding dealer and customer demand for more high-performing implements from Kubota," said Dave Palmer, senior product manager of Kubota hay tools. "Kubota understands that our customers depend on our equipment's productivity and by providing the right tools, we always deliver. Kubota's hay tools are performance-matched to ideally complement our M-Series tractors and deliver a more comprehensive line of haying solutions for our customers' needs."
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7443251-kubota-tractor-hay-tools/
At an ever-increasing rate, CEOs and business executives are relying on their peers, particularly outside their own expertise, to help them grow personally, professionally and organizationally. Yet, many of today’s business leaders have unpredictable travel schedules, live in outlying markets, or simply prefer to connect with their peers online. To meet the needs of these executives, Vistage International, the world’s foremost peer advisory membership organization for business leaders, has launched a new program – a robust online, issue-resolution offering that makes it possible to engage a group of business peers on specific subjects. Vistage Connect provides executives with access to the professionally facilitated “advisory board” they need to process and solve their toughest business challenges and optimize their opportunities. The new online platform has been in the research and test phase for the past year and is now officially available to CEOs and business executives of growing and mature companies.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/vistage/51158/
Nexity, un des leader du marché de l’administration de biens, veut faire émerger des bonnes pratiques et transformer les métiers de services immobiliers aux particuliers. Nexity veut aussi répondre toujours mieux à ses clients propriétaires bailleurs avec des services qui correspondent vraiment à leurs besoins, en phase avec leur mode de vie de plus en plus connecté et mobile. D’où l’idée de leur proposer une nouvelle approche du mandat de gestion locative, 100% en ligne et à un coût particulièrement compétitif !
Beaucoup plus que la simple possibilité pour nos clients de pouvoir consulter en ligne les mouvements comptables correspondant à des mandats traditionnels, e-gérance leur permet, directement en ligne et en trois clics, de confier la responsabilité comptable, administrative et réglementaire à un mandataire expert. Tout en conservant la relation avec leur locataire et la gestion patrimoniale de leur bien.
To view the multimedia release go to:
http://www.multivu.com/players/fr/7747651-nexity-lance-e-gerance-gestion-locative/
ITC Transmission, a wholly-owned subsidiary of ITC Holdings Corp., the nation’s largest independent electricity transmission company, today announced its Thumb Loop high-voltage transmission project is complete with the energization of the third and final phase of the project. ITC invested an estimated $510 million to build the 345,000 volt (345 kV) line, which serves as the backbone of a system designed to meet the identified maximum wind energy potential of Michigan’s Thumb region. It also will contribute to regional system reliability and facilitate wholesale market competition.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7523851-itctransmission-thumb-loop/
BlackRock, Inc. (NYSE: BLK) today announced that its iShares® Exchange Traded Funds (ETFs) business, the world’s largest manager of ETFs, is launching a campaign to assist investors in learning what to look for when selecting an ETF. The initial phase of the campaign is the publication of an Investor ETF Checklist and an accompanying educational video, both available on the iShares website.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/iShares/47109/
Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss
